Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trialGıancarlo Comı, Jeffrey A. Cohen, Ludwig Kappos et al.|The Lancet Neurology|2019Cited by 286
Comparative effectiveness of extracorporeal shock wave, ultrasound, low-level laser therapy, noninvasive interactive neurostimulation, and pulsed radiofrequency treatment for treating plantar fasciitisXian Li, Rui Gao, Zongshi Qin et al.|Medicine|2018Cited by 59